Targets for therapy in sarcomeric cardiomyopathies

To date, no compounds or interventions exist that treat or prevent sarcomeric cardiomyopathies. Established therapies currently improve the outcome, but novel therapies may be able to more fundamentally affect the disease process and course. Investigations of the pathomechanisms are generating molec...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cardiovasc Res
Auteurs principaux: Tardiff, Jil C., Carrier, Lucie, Bers, Donald M., Poggesi, Corrado, Ferrantini, Cecilia, Coppini, Raffaele, Maier, Lars S., Ashrafian, Houman, Huke, Sabine, van der Velden, Jolanda
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2015
Sujets:
Invited Spotlight Reviews
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4402369/
https://ncbi.nlm.nih.gov/pubmed/25634554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cvr/cvv023
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires